(2S,3S)-a-Amino-b-methylvaleric acid en es it fr

(2S,3S)-a-Amino-b-methylvaleric acid Brand names, (2S,3S)-a-Amino-b-methylvaleric acid Analogs

(2S,3S)-a-Amino-b-methylvaleric acid Brand Names Mixture

  • No information avaliable

(2S,3S)-a-Amino-b-methylvaleric acid Chemical_Formula


(2S,3S)-a-Amino-b-methylvaleric acid RX_link

No information avaliable

(2S,3S)-a-Amino-b-methylvaleric acid fda sheet

(2S,3S)-a-Amino-b-methylvaleric acid msds (material safety sheet)

http://www.vinquiry.com/pdf/MSDS/L-Isoleucine MSDS.pdf

(2S,3S)-a-Amino-b-methylvaleric acid Synthesis Reference

No information avaliable

(2S,3S)-a-Amino-b-methylvaleric acid Molecular Weight

131.174 g/mol

(2S,3S)-a-Amino-b-methylvaleric acid Melting Point

168-170 oC

(2S,3S)-a-Amino-b-methylvaleric acid H2O Solubility

No information avaliable

(2S,3S)-a-Amino-b-methylvaleric acid State


(2S,3S)-a-Amino-b-methylvaleric acid LogP


(2S,3S)-a-Amino-b-methylvaleric acid Dosage Forms

Capsules, powder, tablets

(2S,3S)-a-Amino-b-methylvaleric acid Indication

The branched-chain amino acids may have antihepatic encephalopathy activity in some. They may also have anticatabolic and antitardive dyskinesia activity.

(2S,3S)-a-Amino-b-methylvaleric acid Pharmacology

They provide ingredients for the manufacturing of other essential biochemical components in the body, some of which are utilized for the production of energy, stimulants to the upper brain and helping you to be more alert.

(2S,3S)-a-Amino-b-methylvaleric acid Absorption

Absorbed from the small intestine by a sodium-dependent active-transport process

(2S,3S)-a-Amino-b-methylvaleric acid side effects and Toxicity

Symptoms of hypoglycemia, increased mortality in ALS patients taking large doses of BCAAs

(2S,3S)-a-Amino-b-methylvaleric acid Patient Information

No information avaliable

(2S,3S)-a-Amino-b-methylvaleric acid Organisms Affected

Humans and other mammals